definiens: means, with respect to each Compound, Product and/or Companion Diagnostic, all costsactually incurred by [COMPANY] or [COMPANY] and specifically attributable to Development of such Compound, Productand / or Companion Diagnostic, including : 1.26.1actual amounts paid to Third Parties, if any contracted to conduct aspects of such Development work ; 1.26.2internal costs incurred by [COMPANY] or [COMPANY], as the case may be, in connection with such Development(calculated at the FTE Rate ) ; 1.26.3costs for Clinical Trials planning and implementation, Third Party suppliers of clinical services, clinicalsite recruiting, training and participation, monitoring of clinical sites, data analysis and data qualityassurance ; [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filedseparately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934,as amended